Cerberus 1, also known as CER1 or Cerberus-like protein 1, is a member of the DAN (differential screening-selected gene aberrative in neuroblastoma) family of bone morphogenetic protein (BMP) antagonists. This protein plays a pivotal role in early embryonic development, particularly in the formation of the anterior-posterior (head-tail) axis and the specification of the mesoderm and endoderm.CER1 acts by binding and inhibiting several growth factors, including BMPs, nodal, and Wnt ligands, which are critical for embryogenesis and organogenesis. By blocking these signaling pathways, CER1 helps establish the correct developmental gradients necessary for the formation of various tissues and organs.
In the context of BMPs, CER1 inhibits BMP signaling, thus preventing the ectopic formation of ventral and posterior structures. This action is essential for the formation of the dorsal structures in the developing embryo.Regarding nodal and Wnt signaling, CER1's inhibition helps maintain the balance of these pathways. Nodal signaling is crucial for the formation of mesoderm and endoderm, while Wnt signaling is involved in numerous developmental processes such as cell fate specification, proliferation, and migration.In addition to embryonic development, CER1 may have roles in disease processes, with some evidence suggesting its involvement in cancer. Its expression has been found altered in certain types of cancers, pointing towards a role in tumor progression or suppression, depending on the context.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $94.00 $348.00 | 69 | |
Dorsomorphin inhibits BMP signaling by targeting the BMP type I receptors. By inhibiting this pathway, it may indirectly enhance the activity of Cerberus 1. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
LDN-193189 is a potent BMP type I receptor inhibitor and may support Cerberus 1 activity by further inhibiting BMP signaling. | ||||||
DMH-1 | 1206711-16-1 | sc-361171 sc-361171B sc-361171A sc-361171C | 10 mg 25 mg 50 mg 100 mg | $209.00 $312.00 $620.00 $1026.00 | 2 | |
DMH1 is another BMP type I receptor inhibitor. Its inhibition of BMP signaling could synergize with Cerberus 1's antagonistic action. | ||||||
SIS3 hydrochloride | 521984-48-5 | sc-253565 | 5 mg | $334.00 | 2 | |
SIS3 is a specific inhibitor of Smad3, a protein involved in TGF-beta signaling. Its inhibition can affect BMP pathways, potentially supporting Cerberus 1. | ||||||
LDN-214117 | 1627503-67-6 | sc-507451 | 5 mg | $165.00 | ||
LDN-214117 is a potent and selective inhibitor of BMP type I receptors, possibly enhancing the antagonistic effect of Cerberus 1. | ||||||
K02288 | 1431985-92-0 | sc-488981 | 5 mg | $330.00 | ||
K02288 is a potent and selective ALK2 inhibitor, affecting BMP signaling and potentially aiding Cerberus 1's antagonistic role. | ||||||